dihexa fda approval status 2026 Anticipated Decisions for the Second Quarter of Dihexa Aerosol Spray · Disguised

flexible ratios Cycle driver Whichever compound titrates more slowly Cagrilintide Loading 0.25 2.4 mg over ~16 weeks Frequency Once weekly Maintenance 2.4 mg Route SubQ Semaglutide Loading 0.25 2.4 mg over ~16 weeks Frequency Once weekly Maintenance 2.4 mg Route SubQ Weekly Schedule Example (Maintenance) Same day each week Cagrilintide 2.4 mg SubQ + Semaglutide 2.4 mg SubQ Use separate syringes for each compound

Review meds (e.g., metformin, PPIs), medical conditions (GI surgery, malabsorption), and diet with your clinician

This includes quick IV Vitamin B12, watching the patient closely, and being ready for any problems

Medical supervision with enhanced monitoring is essential if considering concurrent use

Inject into subcutaneous tissue over the outer hip, avoiding direct injection into tender points